Skip to main content
OpenTrials

Clinical trial condition

Bacterial Infections

Explore clinical trials studying Bacterial Infections. Study availability and eligibility vary by location and protocol.

4,515 public trials 493 recruiting studies
Refine in advanced search Browse all conditions

Bacterial Infections trial results

Completed

A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study

NCT00307554

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
  • GSK Investigational Site Jyväskylä, Finland
View all 35 locations
View Trial Details
Completed

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

NCT00133848

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations
  • GSK Investigational Site Bangalore, India
  • GSK Investigational Site Hyderabad, India
  • GSK Investigational Site Rome, Lazio, Italy
  • GSK Investigational Site Zapopan, Jalisco, Jalisco, Mexico
View all 22 locations
View Trial Details
Completed

Prospective Assessment of TBDx Feasibility

NCT02912832

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations
  • Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia Lima, Peru
  • Pham Ngoc Thach Hospital Ho Chi Minh City, Vietnam
View Trial Details
Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

NCT00307567

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Eppelheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
View all 51 locations
View Trial Details
Completed

Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

NCT00258700

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Bydgoszcz, Poland
  • GSK Investigational Site Gdansk, Poland
  • GSK Investigational Site Kielce, Poland
  • GSK Investigational Site Krakow, Poland
View Trial Details
Completed

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

NCT00263653

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Almería, Spain
  • GSK Investigational Site Almería, Spain
  • GSK Investigational Site Antequera/Málaga, Spain
  • GSK Investigational Site Aravaca, Spain
View all 16 locations
View Trial Details

Related conditions